ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.43
0.77%
US Tech 100
18,555.60
2.10%
S&P 500
5,354.03
1.18%
US Dollar vs CAD
1.36735
-0.12%
Bitcoin
71,164.33
0.12%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vor Biopharma Inc (VOR)

  7. Vor Biopharma Inc (VOR) News

VOR

Vor Biopharma (VOR)

Vor Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VOR
DateTimeSourceHeadlineSymbolCompany
06/04/20243:01PMGlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
05/28/20243:54PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
05/09/20243:05PMGlobeNewswire Inc.Vor Bio Reports First Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
05/09/20243:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
05/07/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
05/07/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
05/06/20247:00AMGlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
05/03/20243:01PMGlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
05/02/20243:01PMGlobeNewswire Inc.Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of DirectorsNASDAQ:VORVor Biopharma Inc
04/01/20247:00AMGlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
03/20/20243:05PMGlobeNewswire Inc.Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
03/05/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
03/05/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
03/05/20243:01PMGlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
03/04/20247:00AMGlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
02/14/20243:08PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VORVor Biopharma Inc
02/08/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
02/08/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
02/07/20247:00AMGlobeNewswire Inc.Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:VORVor Biopharma Inc
02/02/20243:01PMGlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
01/31/20246:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
01/31/20246:34PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
01/17/20243:01PMGlobeNewswire Inc.Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate UpdateNASDAQ:VORVor Biopharma Inc
01/05/20244:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
12/21/20233:01PMGlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
12/01/20233:01PMGlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
11/27/20237:00AMGlobeNewswire Inc.Vor Bio to Participate in the JMP Securities Hematology and Oncology SummitNASDAQ:VORVor Biopharma Inc
11/09/20233:01PMGlobeNewswire Inc.Vor Bio Presents Positive Data Update on Trem-cel at HSCT² ConferenceNASDAQ:VORVor Biopharma Inc
11/08/20233:14PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
11/08/20233:12PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:VOR

Your Recent History

NASDAQ
AAWQKXX
Toronto Dominion Bank Ca...
BIT
P1UP17
NLBNPIT1UP17 20240621 90
BIT
P1ZMJ4
NLBNPIT1ZMJ4 20241220 45
BIT
P1VMO3
NLBNPIT1VMO3 20991231 85...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved